pyrazolanthrone has been researched along with Cardiac Failure in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Lin, CM; Shyu, KG; Wang, BW | 1 |
| Brown, JH; Gong, X; Lerner, DL; Petrich, BG; Saffitz, JE; Wang, X; Wang, Y | 1 |
2 other study(ies) available for pyrazolanthrone and Cardiac Failure
| Article | Year |
|---|---|
Suppressive effect of epigallocatechin-3-O-gallate on endoglin molecular regulation in myocardial fibrosis in vitro and in vivo.
Topics: Angiotensin II; Animals; Anthracenes; Catechin; Cell Proliferation; Cells, Cultured; Endoglin; Fibrosis; Heart Failure; Immunohistochemistry; JNK Mitogen-Activated Protein Kinases; Male; Models, Biological; Myocardial Infarction; Myocardium; Promoter Regions, Genetic; Protein Binding; Rats, Wistar; RNA, Small Interfering; Signal Transduction; Transcription Factor AP-1 | 2016 |
c-Jun N-terminal kinase activation mediates downregulation of connexin43 in cardiomyocytes.
Topics: Animals; Animals, Genetically Modified; Anisomycin; Anthracenes; Cell Communication; Cell Death; Cells, Cultured; Connexin 43; Down-Regulation; Enzyme Activation; Enzyme Inhibitors; Gap Junctions; Gene Targeting; Heart Failure; Heart Ventricles; JNK Mitogen-Activated Protein Kinases; Mitogen-Activated Protein Kinases; Myocardium; Protein Synthesis Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger | 2002 |